Clorox (NYSE: CLX) files 8-K with Q1 results and financial exhibits

Rhea-AI Filing Summary

The Clorox Company filed a Form 8-K to share its latest quarterly performance information. The company reported that it issued a press release detailing its financial results for the first quarter ended September 30, 2025, and made this document available as Exhibit 99.1.

The filing also includes supplemental financial information as Exhibit 99.2, offering additional detail on the quarter’s results. Together, these materials provide investors and analysts with a fuller picture of Clorox’s recent operating performance and financial condition.

8-K Event Classification

3 items: 2.02, 7.01, 9.01

3 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0000021076False00000210762025-11-032025-11-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 3, 2025

THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)
__________________

Delaware			1-07151			31-0595760
(State or other jurisdiction of			(Commission File Number)			(I.R.S. Employer
incorporation)						Identification No.)

1221 Broadway, Oakland, California 94612-1888
(Address of principal executive offices) (Zip code)

(510) 271-7000
(Registrant's telephone number, including area code)

Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]			Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)
[ ]			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock - $1.00 par value			CLX			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company     ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐

1

Item 2.02 Results of Operations and Financial Condition

On November 3, 2025, The Clorox Company issued a press release announcing its financial results for its first quarter ended September 30, 2025. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 7.01 Regulation FD Disclosure

Attached hereto as Exhibit 99.2 and incorporated herein by reference is supplemental financial information.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

See the Exhibit Index below.

EXHIBIT INDEX

Exhibit						Description
99.1						Press Release dated November 3, 2025 of The Clorox Company
99.2						Supplemental information regarding financial results
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						THE CLOROX COMPANY
Date:			November 3, 2025			By:			/s/ Angela Hilt
									Angela Hilt
									Executive Vice President – Chief Legal and External Affairs Officer & Corporate Secretary

3

FAQ

What did The Clorox Company (CLX) disclose in this Form 8-K?

The Clorox Company filed a Form 8-K to report that it issued a press release announcing financial results for its first quarter ended September 30, 2025, and provided related supplemental financial information.

Which period do the latest Clorox (CLX) results in the 8-K cover?

The results discussed in the Form 8-K relate to The Clorox Company’s financial performance for its first quarter ended September 30, 2025, as described in the attached press release and supplemental financial information exhibits.

Which exhibits are included with The Clorox Company (CLX) Form 8-K?

The Form 8-K includes Exhibit 99.1, a press release dated November 3, 2025, and Exhibit 99.2, supplemental information regarding financial results, along with Exhibit 104, the cover page interactive data file.

How did Clorox (CLX) release its first-quarter 2025 financial results?

Clorox released its first-quarter financial results through a press release dated November 3, 2025, covering the quarter ended September 30, 2025, which is attached to the Form 8-K as Exhibit 99.1.

What is the purpose of the supplemental financial information in Clorox’s (CLX) 8-K?

The supplemental financial information, filed as Exhibit 99.2, provides additional detail supporting Clorox’s first-quarter results, complementing the primary press release and helping users better understand the company’s recent financial performance.

Who signed The Clorox Company (CLX) Form 8-K?

The Form 8-K was signed on behalf of The Clorox Company by Angela Hilt, who serves as Executive Vice President, Chief Legal and External Affairs Officer, and Corporate Secretary.